- $50.04m
- $31.72m
- $27.48m
Sensus Healthcare Inc expected to post earnings of 13cents a share - Earnings Preview
Brief: Sensus Healthcare Q2 Revenue Rose 124 Percent To $12.1 Million
Brief: Sensus Healthcare Takes Order For 10 Transdermal Infusion Systems Supporting Hair Enhancement Centers Expansion Along With U.SK Under Skin's Hair-Health Serum
Sensus Healthcare Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sensus Healthcare Q1 Revenue Rose 237% To $10.3 Million
Sensus Healthcare Inc expected to post earnings of 33 cents a share - Earnings Preview
Brief: Mata Mata Turtle With Squamous Cell Carcinoma Successfully Treated With Sensus Healthcare's Srt System By Colorado State University Veterinarian
Brief: Sensus Healthcare Announces Share Repurchase Program
Brief: Press Release - Sensus Healthcare Sells Its Sculptura™ Assets To Empyrean Medical Systems For $15 Million In Cash
U.S. STOCKS ON THE MOVE-Chipmakers, RumbleOn, Grab, Rivian, Macy's, Target
H.C. Wainwright expects Sensus Healthcare to see strong 2022 growth
Sensus Healthcare Inc reports results for the quarter ended in December - Earnings Summary
Brief: Sensus Healthcare Reports Results For The 2021 Fourth Quarter
Sensus Healthcare Inc expected to post earnings of 15 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Cooper Companies, Docusign, Ulta Beauty
Brief: Sensus Healthcare Signs Exclusive U.S. Distribution Agreement With Mattioli Eng. Italia For Its Transdermal Infusion System
Sensus Healthcare Inc reports results for the quarter ended in September - Earnings Summary
Sensus Healthcare Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Chinese Health Authority Renews License For Sensus Healthcare’s SRT-100 For Five More Years